Avecho Biotechnology (AVE) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock AVE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Avecho Biotechnology Secures R&D Tax Incentive to Advance CBD Insomnia TreatmentMay 27, 2025 | tipranks.comAvecho Biotechnology Secures Shareholder Support at AGMMay 27, 2025 | tipranks.comAvecho Biotechnology Issues Unquoted Securities to Align Workforce InterestsMay 27, 2025 | tipranks.comAvecho Secures Major Partnership with Sandoz for CBD Sleep TreatmentMay 26, 2025 | tipranks.comAvecho Biotechnology Limited Announces 2025 Annual General MeetingApril 23, 2025 | tipranks.comAvecho Biotechnology Issues Shares Under Equity Incentive PlanApril 16, 2025 | tipranks.comAvecho Biotechnology to Present at NWR Virtual Healthcare Conference Amid Major Licensing DealMarch 12, 2025 | tipranks.comAvecho Biotechnology Hosts Investor Webinar Amidst Key Licensing Agreement and Clinical Trial ProgressMarch 3, 2025 | tipranks.comAvecho Biotechnology Sees Revenue Surge Amidst Continued R&D InvestmentsFebruary 27, 2025 | tipranks.comAvecho Biotechnology Advances CBD Trial and Strengthens Manufacturing TiesJanuary 30, 2025 | tipranks.comAvecho Biotechnology Updates on Director InterestsDecember 1, 2024 | tipranks.com Get Avecho Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for AVE and its competitors with MarketBeat's FREE daily newsletter. Email Address AVE Media Mentions By Week AVE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVE News Sentiment▼0.000.58▲Average Medical News Sentiment AVE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVE Articles This Week▼00▲AVE Articles Average Week Get Avecho Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for AVE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SVA News HBP News MBX News SBTX News FUM News HYPD News SAR News GSD News HEM News AREC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:AVE) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avecho Biotechnology Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Avecho Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVE Stock Alerts